CASSANDRA HENDERSON: Open Payments
NPI 1184396848 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,452 in 83 payments from 18 companies in 2025. Trend: 2023 $1,863 · 2024 $1,634 · 2025 $1,452
Food & beverage: $1,452
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 28 | $372 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $243 |
| Lilly USA, LLC | 9 | $156 |
| Corcept Therapeutics | 6 | $115 |
| Amgen Inc. | 5 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| ABBVIE INC. | 3 | $59 |
| Soleno Therapeutics, Inc. | 2 | $53 |
| Tandem Diabetes Care, Inc. | 3 | $44 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
Products named: Kerendia, Wegovy, MOUNJARO, Korlym, Ozempic, Rybelsus, TEPEZZA, LEQVIO.
Industry payments across TX — which companies pay providers there.
